# INNATE PHARMA S A (IPHA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IPHA/

- Reporting holders: 2
- Reported value: $31
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $16 | 10 | 0.0% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $15 | 9 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $31 |
| Q2 2026 | 10 | $376.9K |
| Q1 2026 | 9 | $235.5K |
| Q4 2025 | 11 | $483.5K |
| Q3 2025 | 9 | $157.9K |
| Q2 2025 | 9 | $178.7K |
| Q1 2025 | 10 | $281.6K |
| Q4 2024 | 9 | $254.8K |
| Q3 2024 | 8 | $545.1K |
| Q2 2024 | 8 | $469.0K |
| Q1 2024 | 9 | $985.4K |
| Q4 2023 | 8 | $490.7K |